Elite Pharmaceuticals, Inc. (ELTP)
0.2875
0.00 (0.00%)
USD |
OTCM |
Aug 31, 16:00
Elite Pharmaceuticals Cash from Investing (Quarterly) : -0.809M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.809M |
| March 31, 2026 | -0.398M |
| December 31, 2025 | -0.2061M |
| September 30, 2025 | -0.1033M |
| June 30, 2025 | -0.2182M |
| March 31, 2025 | -0.7541M |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.0176M |
| June 30, 2024 | -1.663M |
| March 31, 2024 | -0.4036M |
| December 31, 2023 | -0.406M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | -0.5362M |
| December 31, 2022 | -0.0007M |
| September 30, 2022 | -5.105M |
| June 30, 2022 | -0.0946M |
| March 31, 2022 | -0.2642M |
| December 31, 2021 | -0.0821M |
| September 30, 2021 | -0.1474M |
| June 30, 2021 | -0.005M |
| March 31, 2021 | -0.1849M |
| December 31, 2020 | -0.0377M |
| September 30, 2020 | -0.0774M |
| June 30, 2020 | 0.0373M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.0318M |
| December 31, 2019 | 0.00 |
| September 30, 2019 | -0.0002M |
| June 30, 2019 | -0.003M |
| March 31, 2019 | 0.35M |
| December 31, 2018 | -0.0191M |
| September 30, 2018 | 0.1786M |
| June 30, 2018 | -0.1786M |
| March 31, 2018 | 0.1009M |
| December 31, 2017 | 0.0846M |
| September 30, 2017 | -0.1269M |
| June 30, 2017 | -0.3358M |
| March 31, 2017 | -0.2929M |
| December 31, 2016 | -0.2927M |
| September 30, 2016 | -0.2349M |
| June 30, 2016 | -0.2845M |
| March 31, 2016 | -0.5708M |
| December 31, 2015 | 0.0455M |
| September 30, 2015 | -0.7072M |
| June 30, 2015 | -0.7163M |
| March 31, 2015 | -0.5988M |
| December 31, 2014 | -0.3844M |
| September 30, 2014 | -0.3778M |
| June 30, 2014 | 4.240M |
| March 31, 2014 | -0.0643M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Nektar Therapeutics | -399.11M |
| Daré Bioscience, Inc. | -0.0806M |
| Eton Pharmaceuticals, Inc. | 0.005M |
| ANI Pharmaceuticals, Inc. | -3.054M |
| Corcept Therapeutics, Inc. | -29.24M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 10.07M |
| Cash from Financing (Quarterly) | -0.1146M |
| Free Cash Flow | 17.53M |
| Free Cash Flow Per Share (Quarterly) | 0.0082 |
| Free Cash Flow to Equity (Quarterly) | 9.504M |
| Free Cash Flow to Firm (Quarterly) | 9.317M |
| Free Cash Flow Yield | 5.43% |